Sign in

Silgan Holdings Inc. SLGN

Price 41.5 USD
as of 2026-09-04
47/100
Mixed
Quality47
Growth55
Balance-sheet strength25
Valuation67
Momentum39
Income60

Composite 47/100; the shares have moved about 35% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.

Strongest counter-signal

Balance-sheet strength ranks 25/100 — a moderate mark against it.

Case for

Valuation ranks 67/100 — a moderate point in its favour. Income ranks 60/100 — a slight point in its favour. Growth ranks 55/100 — a slight point in its favour.

Case against

Balance-sheet strength ranks 25/100 — a moderate mark against it. Momentum ranks 39/100 — a slight mark against it. Quality ranks 47/100 — a slight mark against it.

What the company does Silgan Holdings (SLGN) makes rigid packaging—closures, metal containers, and custom plastic solutions—used by food, beverage, beauty, and home-care brands.

Key financials ROE 12.9%, ROA 4.5%, gross margin 17.4%, operating margin 8.7%, net margin 4.3%. Revenue grew 6.5% but EPS fell -5.2%. Debt/Equity 2.03, net debt/EBITDA 4.58, current ratio 2.33.

Stock health 12-month return -24.94%, RSI 36.90, trading -19.12% below its 52-week high. Sideravia scores Valuation 71.6 (attractive) but Quality 45.3 and Momentum 39.2 (below average).

Price vs fair value SLGN trades at a PREMIUM of 31.30% to our fair-value estimate and a discount of 33.39% to the analyst 12-month target. - Q2 CY2026 revenue beat (StockStory) - Q2 earnings call highlights emphasize strong sales growth (GuruFocus.com) - Bullish 12-month target of 54.77 from 13 analysts (analyst count 13.0)

Looking forward Forward P/E 12.22, PEG 0.29, FCF yield 7.1%, dividend yield 1.7% with 30.3% payout. Analysts see potential upside to 54.77, offset by valuation premium to our 28.21 estimate.

sideravia.comEvery stock argues both sides.
Research, not advice · sideravia.com/conflicts — read the policy

This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.

Data as of 2026-09-04, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.